Clinical Trials Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 14, 2014; 20(22): 6981-6988
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6981
Table 1 General clinicopathological features of patients enrolled in the study (mean ± SD)
Total gastrectomyDistal gastrectomyProximal gastrectomy
Number of patients353430
Gender (male/female)20/1519/1519/11
Smoking (yes/no)19/1618/1618/12
Drinking (yes/no)17/1818/1617/13
Age (yr)62.49 ± 9.6963.68 ± 9.4859.40 ± 10.61
Body mass index (kg/m2)20.55 ± 4.0220.92 ± 2.5719.70 ± 2.43
Hemoglobin (g/L)114.83 ± 26.00125.59 ± 24.99122.23 ± 21.46
Lymphocyte count (109/L)1.61 ± 0.501.34 ± 0.471.65 ± 0.51
Albumin (g/L)38.43 ± 4.9241.58 ± 3.5040.99 ± 1.85
Pre-albumin (mg/L)252.20 ± 60.65282.71 ± 70.35262.23 ± 45.65
RDQ score pre-operation3.77 ± 2.583.35 ± 2.363.50 ± 2.36
GERD-Q score pre-operation1.49 ± 1.151.47 ± 1.051.63 ± 1.40
Days in hospital pre-operation3.09 ± 0.923.06 ± 0.923.00 ± 0.87
Days to peri-bed activities post-operation1.14 ± 0.361.12 ± 0.331.13 ± 0.35
Days to borborygmus recovery post-operation1.51 ± 0.511.56 ± 0.501.57 ± 0.50
Flatus duration post-operation (d)3.11 ± 0.633.29 ± 0.803.47 ± 0.68
Transverse diameter of tumor (cm)4.71 ± 1.874.90 ± 1.464.78 ± 2.04
Longitudinal diameter of tumor (cm)4.06 ± 1.864.20 ± 1.154.40 ± 1.54
Depth of tumor (cm)1.41 ± 0.641.66 ± 0.471.16 ± 0.66
Tumor stage (early/advanced)4/315/293/27
Tumor differentiation (well/moderately/poorly)6/15/147/12/154/13/13
Tumor TNM classification (I/II/III)14/5/267/6/213/8/19
Postoperative NRS score3.34 ± 0.973.32 ± 0.983.30 ± 1.02
Table 2 Results of multiple linear regression suggesting potential factors influencing gastric pH pre-gastrectomy
bbtP value
Gender-0.062-0.020-0.2700.788
Age0.0360.2492.4610.016c
Body mass index0.0310.0670.9190.361
Tumor size0.1320.1762.4010.019c
Tumor location0.0990.1081.3710.174
TNM classification-0.032-0.048-0.4360.664
Differentiation grade0.4930.3592.8660.005d
Potassium ion-0.053-0.222-2.3170.023c
Sodium ion0.0010.0220.2240.823
Bicarbonate ion0.5840.2102.1220.037c
Urea nitrogen0.0870.0901.1450.256
Direct bilirubin-0.244-0.030-0.4400.661
Indirect bilirubin0.2540.1081.3470.182
Total bile acid0.0510.0430.5820.562
Table 3 Results of multiple linear regression suggesting possible factors influencing reflux syndrome change (6 mo post- minus pre-gastrectomy)
ScalebbtP value
GenderRDQ-1.342-0.139-1.3930.167
GERD-Q-0.604-0.098-1.0460.299
AgeRDQ0.0720.1601.5060.136
GERD-Q0.0560.1941.9520.054
Body mass indexRDQ0.3390.2652.6290.010c
GERD-Q0.2270.2772.9390.004d
TNM classificationRDQ-0.119-0.059-0.5460.587
GERD-Q-0.014-0.011-0.1080.914
pHRDQ0.1210.0170.170.865
GERD-Q-0.142-0.031-0.3310.741
Potassium ionRDQ0.0790.1551.2950.099
GERD-Q0.0740.2272.0250.046c
Sodium ionRDQ0.0170.1171.1370.259
GERD-Q0.0130.1361.4170.160
Bicarbonate ionRDQ0.3810.1982.0190.147
GERD-Q0.1920.1561.7010.193
Urea nitrogenRDQ-0.074-0.087-0.7810.437
GERD-Q-0.070-0.129-1.2420.218
Direct bilirubinRDQ-0.985-0.374-2.9700.004d
GERD-Q-0.704-0.416-3.5420.001d
Indirect bilirubinRDQ0.0770.2522.2510.027c
GERD-Q0.0730.3743.5850.001d
Total bile acidRDQ0.0050.1781.5170.033c
GERD-Q0.0050.2722.4850.015c
Table 4 Gastrointestinal juice contents pre- and 6 mo post-gastrectomy in the 3 groups
Gastric juice contentWay of gastrectomyPre-gastrectomySix months post-gastrectomy
Potassium ion (mmol/L)TG11.77 ± 4.4116.54 ± 11.80
DG14.18 ± 5.7012.65 ± 5.90
PG16.80 ± 7.1716.80 ± 6.55
Sodium ion (mmol/L)TG56.16 ± 34.09111.68 ± 36.06
DG78.68 ± 21.71104.10 ± 23.27
PG54.32 ± 25.4489.06 ± 27.44
Bicarbonate ion (mmol/L)TG1.05 ± 0.524.36 ± 2.51
DG1.19 ± 0.473.28 ± 2.09
PG1.19 ± 0.583.58 ± 2.25
Urea nitrogen (mmol/L)TG3.63 ± 0.8310.60 ± 6.00
DG4.80 ± 1.589.74 ± 4.83
PG4.42 ± 1.807.17 ± 4.39
Direct bilirubin (μmol/L)TG0.17 ± 0.160.87 ± 1.40
DG0.14 ± 0.172.20 ± 1.92
PG0.16 ± 0.211.39 ± 1.43
Indirect bilirubin (μmol/L)TG0.49 ± 0.5513.61 ± 12.74
DG0.64 ± 0.6517.85 ± 11.91
PG0.61 ± 0.6523.41 ± 17.56
Total bile acid (μmol/L)TG1.98 ± 1.32187.13 ± 199.14
DG3.00 ± 1.08212.94 ± 103.39
PG2.73 ± 1.00232.21 ± 126.40